Navigation

Lab Notebook

Comprehensive documentation of our 2025 experimental procedures, protocols, and findings for ASO and aptamer development.

ASO Experiments

cDNA synthesis, qPCR setup, and protein knockdown assays

Aptamer Development

Cell treatment, staining protocols, and imaging procedures

Data Analysis

Results interpretation and experimental optimization

July 14, 2025 - cDNA Synthesis

Protocol Overview

Used the ProtoScript® II First Strand cDNA Synthesis Kit for reverse transcription.

Materials and Reagents

All reagents were taken out from -20°C and kept on ice throughout the procedure.

Procedure

Initial Mix (for each sample)

  • RNA
  • Oligo(dT)₂₀ primer
  • dNTP Mix (10 mM each)
  • Nuclease-free water

Tubes were given a quick spin in the centrifuge to bring everything down. No heat block or ice incubation was used after mixing — tubes were kept chilled while moving on.

Reverse Transcription Mix

Added the following components directly into the same tubes:

  • 10X Reaction Buffer
  • 0.1 M DTT
  • RNase Inhibitor (40 U/µL)
  • ProtoScript® II Reverse Transcriptase (200 U/µL)
  • Nuclease-free water to bring total volume

Thermocycler Program

Mixed the reaction gently by pipetting and did another quick spin in the centrifuge. Placed tubes in the thermocycler and ran:

  • X°C for X minutes
  • X°C for X minutes

July 16, 2025 - ASO Plate Setup

Objective

Set up plates with ASO for protein knockdown experiments.

Procedure

Dosage Calculations

We wanted a final dose of 5 micromolar of ASO. ASO is originally a 10x mix, and we calculated that we would need to add 2.5 microliter of ASO to get our final dose.

Master Mix Preparation

  • Made a master mix of 100 microliters of OPTI-MEM and 1 microliter of Lipo 3000
  • Added 7.5 microliters of ASO for every 300 microliters of Master Mix
  • Let it incubate for 10 minutes
  • Added 100 microliters of ASO master mix to each well
  • Wait for 5 days, then image the results. We will check on the cells after 24 hours, because lipofection can be toxic to the cell.

Observations

Initial Cell Confluence

When we started, we observed that there was around 70% confluence of cells in the wells (the cells covered approximately 70% of the plate).

ASO Master Mix Quality

While making our ASO master mix, we noted that after our 10 minute incubation period:

  • Less cloudy (potential concern): E7, D11, F10, and F2 ASOs were not that cloudy
  • Cloudy (optimal): F8 and E9 were cloudy

This could affect the results of our experiment, as increased cloudiness correlates to more effective formation of complexes.

Upcoming Plans

We will finish setting up a qPCR plate and run the qPCR. Once that is complete, we will do some data analysis and get some imaging done.

July 17-18, 2025 - qPCR Setup and Execution

July 17: Preparation for qPCR Plate

Sample Assessment

When we observed the samples, we recorded that samples 1, 3, 4 (maybe), 5, 9, 11, 22 (maybe) may be uneven in sample size but we are proceeding with the qPCR.

Volume Calculations

Completed all calculations for plating. Using the amount of cDNA (245 µM) calculated previously, we were able to determine how much µL of ddH₂O each of the replicates required for both the +dox and -dox samples.

Reaction Composition

We are going to pipette 10 µL in each reaction:

  • 4.5 µL is going to be ddH₂O + cDNA
  • 5.0 µL is Poner Syber MM
  • 0.5 µL is forward and reverse primers at 10 µM
    • 0.25 µL Forward + 0.25 µL Reverse

cDNA Dilution Calculation

Using M₁V₁ = M₂V₂ we were able to determine that 0.14694 µL is required to dilute the 245 ng of cDNA into 4.5 µL of 8.0 ng/µL cDNA.

ASO Plate Setup

Upcoming plans

Now that we finished labeling and setting up our qPCR plate, we are going to pipette samples and run the experiment

July 18: Running qPCR Experiment

Sample Volume Verification

First we needed to redo our calculations and also account for the discrepancies in the samples of cDNA that had less than ideal amounts. Using a pipette, we measured how many µL of cDNA were actually in the following samples:

Sample 1: 11 µL
Sample 1 - 11µL
Sample 3: 11 µL
Sample 3 - 11µL
Sample 4: 12 µL
Sample 4 - 12µL
Sample 5: 15 µL
Sample 5 - 15µL
Sample 9: 13 µL
Sample 9 - 13µL
Sample 11: 8 µL
Sample 11 - 8µL
Sample 22: 10 µL
Sample 22 - 10µL

We are assuming that all the other samples have around 20 µL of cDNA.

Calculation Example (Sample 14)

Based on our qPCR setup with METTL3, YTHDF2, and a control group, we calculated how much cDNA and DDH₂O each reaction contained.

For example, the first group, 14, testing METTL3, cryptic exon, full exon, and GAPDH:

  • Has 3 technical replicates → total of 15 reactions
  • Added 3 extra reactions for pipetting error → 18 reactions total
  • 8 ng cDNA per reaction × 18 reactions = 144 ng total cDNA needed
  • 5.0 µL Poner Syber MM × 18 = 90 µL
  • 0.5 µL primer × 18 = 9 µL

Calculating cDNA volume needed:

144 ng ÷ 245 ng/µL × 20 µL = 11.75 µL of cDNA stock

Total reaction volume calculation:

10 µL × 18 reactions = 180 µL total

180 µL - 90 µL (MM) - 9 µL (primer) - 11.75 µL (cDNA) = 69.25 µL of DDH₂O

We repeated the above for all the wells in the chart and accounted for the lower amounts of cDNA in the listed numbers above.

Next Steps

Next visit, finish adding the ddH₂O based on the calculations on the spreadsheet.

July 21-24, 2025 - RNA Extraction and Processing

July 21: Extract RNA and Complete qPCR

What we did: Extract RNA and complete qPCR

July 22: Nanodrop Analysis

How to Use a Nanodrop

  1. Add blanks on all 8 spots (the blank is the same solution the RNA was diluted in)
  2. Clean all spots with ddH₂O on a kim wipe
  3. Add 1 microliter of each sample to each of the 8 wells, close the nanodrop, and let the system run
  4. Ratios 260/280 and 230/280 indicate the purity of the sample; anything above 1.90 indicates low contamination
  5. Repeat for all samples

Pipetting Amounts for ProtoScript® II Kit

Determine pipetting amounts:

  1. Record all the concentrations determined from the nanodrop
  2. Determine total well amount that will result in >1 microliter pipetted for each sample (in this case, it was 265 microliters)

Pipetting amounts per sample:

  • RNA: 265/concentration (should be >1 microliter, varies per sample)
  • ddH₂O: 6 - RNA volume
  • Master mix: We accounted for 2 extra wells for pipetting error
    • 26×2 microliters of Oligo(dT)₂₀ primer
    • 26×2 µL dNTP Mix (10 mM each)
    • 26×10 microliters of reaction buffer
ASO Plate Setup

Adding Primer to qPCR Plate

  • There are 13 reactions being tested for each protein in rows 1-5, so we multiplied 14 (to account for pipetting error) by 5.5 µL of —- to calculate a total of 77 µL for each: METTL3, TDP43, full exon, cryptic exon, and GAPDH
  • We repeated this process for rows 6-10, only replacing METTL3 for YTHDF2, and pipetted another 5.5 µL of — in each corresponding well
  • For rows 11-22, the control group, we are testing 23 reactions for each protein (METTL3, YTHDF2, TDP43, full exon, cryptic exon, and GAPDH), so we multiplied 24 reactions (account for pipetting error) by 5.5 µL of — to calculate a total of 132 µL for each proteins — of which we added 5.5 into each corresponding well
  • Using a multichannel pipette, we added 5.5 of the respected protein’s—- to each corresponding well

We then ran the qPCR and will analyze the results

July 23: Prepare for qPCR Plate

Updated Calculations

Completed all calculations for plating. Using the amount of cDNA (265 µM) calculated previously, we determined dilution requirements.

Reaction composition (10 µL total):

  • 4.5 µL ddH₂O + cDNA
  • 5.0 µL Poner Syber MM
  • 0.5 µL primers (0.25 µL Forward + 0.25 µL Reverse) at 10 µM

Updated cDNA dilution:

Using M₁V₁ = M₂V₂: 0.135849 µL is required to dilute the 265 ng of cDNA into 4.5 µL of 8.0 ng/µL cDNA.

ASO Plate Setup

Calculation Example (Sample 1)

Sample 1, testing METTL3, cryptic exon, full exon, and GAPDH:

  • 3 technical replicates = 15 reactions
  • Added 3 extra for error = 18 reactions
  • 8 ng cDNA × 18 = 144 ng total
  • 144 ng ÷ 265 ng/µL × 20 µL = 10.87 µL cDNA needed

Total volume calculation:

180 µL (10 × 18) - 90 µL (MM) - 9 µL (primer) - 10.87 µL (cDNA) = 70.13 µL DDH₂O

July 24: Thermocycling and Plating

Sample Preparation

Samples 12 and 13 did not have enough master mix so we had to re-mix both samples.

Thermocycle program:

  • 25°C for 5 minutes
  • 42°C for 1 hour
  • 12°C on hold

Detailed Calculation Example (SND-1)

Before beginning plating for the qPCR, we calculated cDNA and ddH₂O amounts for each well.

For SND-1 triplicates (6 reactions + 1 extra = 7 reactions):

  1. Concentration calculation: 7 reactions × 8 ng/µL = 56 ng/µL total
  2. Stock volume needed: 56 ng/µL ÷ 265 µL total cDNA = 0.21132075471
  3. From 20 µL stock: 0.21132075471 × 20 µL = 4.23 µL cDNA

ddH₂O calculation for 7 reactions:

  • Total volume: 10 µL × 7 = 70 µL
  • Components:
    • cDNA: 4.23 µL
    • Poner Syber MM: 5.0 µL × 7 = 35 µL
    • Primers: 0.5 µL × 7 = 3.5 µL
  • ddH₂O: 70 - 35 - 3.5 - 4.23 = 27.27 µL
  • After completing calculations for all reactions 1-24, we mixed the calculated cDNA with ddH₂O to create diluted cDNA mixes, then pipetted 4.5 µL of diluted mix into each corresponding well.

July 29-30, 2025 - qPCR Completion and Analysis

July 29: Master Mix Preparation

Cyber and Primer Calculations

We finished adding 4.5 µL of diluted cDNA to the remaining wells and moved on to adding the cyber and primer master mix.

Primer counts and calculations:

  • SND: 57 wells × 1.1 (10% error) = 63 wells
    • Cyber: 5 µL × 63 = 315 µL
    • Primer: 0.5 µL × 63 = 31.5 µL
  • FAM: Same as SND (315 µL cyber, 31.5 µL primer)
  • DAZ: Same as SND (315 µL cyber, 31.5 µL primer)
  • GAPDH: 91 wells × 1.1 = 100 wells
    • Cyber: 5 µL × 100 = 500 µL
    • Primer: 0.5 µL × 100 = 50 µL

Primer Efficiency Curve Setup

We decided to simultaneously run our experiment for establishing a primer efficiency curve to see how well our primers were absorbed to amplify the RNA sequence.

Serial dilutions performed:

Dilution Concentration (ng)
18
1:24
1:42
1:81
1:160.5
1:320.25

Dilution preparation (using samples 14 and 15):

  • Mixed samples 14 and 15: total 16 ng
  • 4.5 µL per well × 3 wells = 13.5 µL per primer
  • 4 primer sets × 13.5 µL = 54 µL (account for 60 µL)
  • Serial dilutions require 60 µL × 2 = 120 µL total

Scaling calculations:

  • Scaling factor: 120 ÷ 31.5 = 3.80
  • DNA: 4.23 µL × 3.87 = 16.11 µL
  • ddH₂O: 27.27 µL × 3.87 = 103.89 µL

July 30: qPCR Run and Results

Execution

We ran the qPCR plate, but the experiment failed.

Issues Encountered

  • Got many N/A values for primer efficiency curve readings
  • Standard deviations were very high (later redone)
  • Possible ddH₂O contamination identified

Materials Note

Used Bio-Rad Microseal B Adhesive Sealer

August 7, 2025 - Aptamer Project Initiation

Overview

Started aptamer project with cell treatment and fixation protocol.

Initial Treatment

Rachel added sodium arsenic to the top right 4 cells while we were gone.

Cell Plate Layout

1 3 2 (arsenic) 2 (arsenic)
3 (arsenic) (arsenic)

Note: Rachel added sodium arsenic to the top right 4 cells while we were gone.

Fixation Protocol

PFA Treatment

  • Used M₁V₁=M₂V₂ to calculate PFA needed
  • Made solution: 10mL of 20% PFA + 40mL ddH₂O
  • Fixed for 15 minutes on rocker

Permeabilization Step

  • Solution: PBST (PBS + 0.3% Triton-X)
  • Duration: 15 min on rocker at RT
  • Purpose: Physiological pH and osmolarity (Open up cell membrane so aptamer can bind)

Washing

  • Solution: PBS
  • Frequency: 3 × 5 min on rocker
  • Purpose: Removes residual Triton X-100 and cellular debris

Blocking Buffer

  • Composition: PBS, 5% donkey serum, 1 microliter of hsDNA
  • Duration: Rocked for ~45 minutes

Post-Blocking Wash

  • Solution: PBS
  • Frequency: 3 × 5 min on rocker
  • Purpose: Removes excess blocking buffer components

Primary Antibody Step

  • Solution: Blocking buffer + 0.67µM aptamer
  • Duration: Overnight at 4°C on rocker
  • Purpose: Aptamer binds specifically to its molecular target

August 8, 2025 - Day 2 Protocol (4 hours)

Washing Steps

PBS wash: 3 × 5min on rocker

Pre-blocking

  • Solution: BSA + PBST (5mL of 1% BSA + 0.3% TritonX)
  • Duration: 30 min on rocker at RT

Blocking with NeutrAvidin

Dilution Calculation

Target: 10mg/mL to 10 µg/mL

  • Add 1 µL of 10mg/mL stock
  • Add 999 µL of preblocking solution (1% BSA + 0.3% TritonX)
  • Final: 1 mL of 10 µg/mL NeutrAvidin

Incubation

  • Solution: NeutrAvidin + BSA + PBST
  • Duration: 15 min on rocker at RT

Post-Blocking Wash

PBS wash: 3 × 5min on rocker

D-biotin Saturation

Purpose

To saturate free streptavidin binding sites

Preparation

  • 1 µL D-biotin
  • 999 µL PBST
  • Final volume: 1 mL

Incubation

  • Solution: D-biotin + PBST
  • Duration: 15 min on rocker at RT

Final Wash

PBS wash: 3 × 5min on rocker

Staining

  • Solution: NeutrAvidin–DyLight 550 conjugate + 1% BSA pre-blocking solution
  • Duration: 60 min on rocker at RT

Post-Staining Wash

PBS wash: 3 × 5min on rocker

DAPI Counterstain

  • Solution: DAPI 1:1000 in PBS
  • Duration: 5 min on rocker at RT

August 11, 2025 - Imaging (SY5Y cells)

Final Steps

Staining

  • Solution: NeutrAvidin–DyLight 550 conjugate + 1% BSA pre-blocking solution
  • Duration: 60 min on rocker at RT

Washing

PBS wash: 3 × 5 min on rocker

DAPI Counterstain

  • Solution: DAPI 1:1000 in PBS
  • Duration: 5 min on rocker at RT

Imaging

Image cells for analysis

September 5, 2025 - Revised Aptamer Protocol

Protocol Steps

Permeabilization

  • Solution: PBST (PBS + 0.3% Triton-X)
  • Duration: 15 min on rocker at RT
  • Purpose: Physiological pH and osmolarity (Open up cell membrane so aptamer can bind)

Washing

  • Solution: PBS
  • Frequency: 3 × 5 min on rocker
  • Purpose: Removes residual Triton X-100 and cellular debris

Blocking Buffer

  • Composition: PBS, 5% donkey serum, 1 microliter of hsDNA (4 mL total)
  • Duration: Rocked for ~45 minutes

Post-Blocking Wash

  • Solution: PBS
  • Frequency: 3 × 5 min on rocker
  • Purpose: Removes excess blocking buffer components

Primary Antibody Step

  • Solution: Blocking buffer + 1.007µM aptamer
  • Duration: Overnight at 4°C on rocker
  • Purpose: Aptamer binds specifically to its molecular target
  • Note: TDP-43 from rabbit background

Changes from Previous Experiment

  • Only adding aptamer in first and third well
  • Blocking buffer with 0.1% triton X

Experimental Layout

Condition Volume
Aptamer Only 1 mL aptamer
Antibody Only -
Both 1 mL aptamer

Experimental Analysis and Optimization

ASO qPCR Analysis

Sample Quality Assessment

Throughout our experiments, we monitored sample quality and volumes to ensure accurate results. Key observations included:

Parameter Observation Impact
Cell Confluence ~70% at start Optimal for transfection
ASO Cloudiness Variable (E7, D11, F10, F2 less cloudy) May affect complex formation efficiency
cDNA Volumes 8-20 µL range Required individual calculations per sample
Nanodrop Ratios 260/280 and 230/280 >1.90 indicates low contamination

Primer Efficiency Optimization

MCTS Iteration Analysis

We tested multiple iterations (n=10) to balance diversity and convergence. Key findings:

  • Initial iterations (1-5) showed rapid score improvement
  • Iterations 5-10 provided optimal balance
  • Beyond 10 iterations: diminishing returns due to sequence convergence

Random Seed Selection

Tested seeds 1001-1005. Seed 1004 consistently produced higher-scoring aptamers and was selected for production runs.

Data Integrity and Troubleshooting

Common Issues Encountered

qPCR Run Failure (July 30)

Issue Symptoms Likely Cause Resolution
N/A Values Multiple wells showing no signal Primer efficiency issues or contamination Rerun with fresh reagents
High Standard Deviation Poor technical replicate consistency Pipetting errors or sample degradation Increased pipetting care; fresh samples
ddH₂O Contamination Unexpected amplification in negative controls Contaminated water stock New ddH₂O aliquot

Sample Volume Discrepancies

Measured vs Expected Volumes

Direct pipette measurements revealed several samples with less than expected volume:

Low Volume Samples
  • Sample 11: 8 µL (expected ~20 µL)
  • Sample 22: 10 µL (expected ~20 µL)
  • Sample 1: 11 µL (expected ~20 µL)
  • Sample 3: 11 µL (expected ~20 µL)
Resolution Strategy
  • Measured actual volumes directly
  • Adjusted calculations per sample
  • Maintained consistent ng/µL concentration
  • Recalculated ddH₂O requirements

Protocol Refinements

ASO Transfection Optimization

  • Cell Confluence: Maintained 70% for optimal uptake
  • Lipofection: Monitored at 24h for toxicity
  • Incubation Time: 10 min for complex formation (increased cloudiness correlates with better complexes)
  • Imaging Timeline: 5 days post-transfection

Aptamer Protocol Modifications (Sept 5)

  • Increased aptamer concentration: 0.67µM → 1.007µM
  • Modified blocking buffer: Added 0.1% Triton X
  • Selective well treatment: Only first and third wells
  • Added TDP-43 antibody control (rabbit background)

Calculation Standards and Best Practices

Master Mix Calculations

General Formula

For any qPCR setup with technical replicates:

Step-by-Step Process
  1. Determine reaction count: Technical replicates × conditions
  2. Add pipetting error margin: Multiply by 1.1-1.2 (10-20% extra)
  3. Calculate total cDNA needed: ng per reaction × total reactions
  4. Determine cDNA volume from stock: (Total ng needed ÷ Stock concentration) × Stock volume
  5. Calculate other components: Multiply per-reaction volumes by total reactions
  6. Calculate ddH₂O: Total volume - (all other components)

Example Calculation Template

Given:
- Target gene: [Gene name]
- Technical replicates: 3
- Primers tested: [METTL3, TDP43, full exon, cryptic exon, GAPDH] = 5
- Reactions per condition: 3 × 5 = 15
- With error (×1.2): 18 reactions

Per reaction (10 µL total):
- cDNA: 8 ng (in 4.5 µL with ddH₂O)
- Syber MM: 5.0 µL
- Primers: 0.5 µL (0.25 µL forward + 0.25 µL reverse)

Calculations:
1. Total cDNA needed: 8 ng × 18 = 144 ng
2. cDNA volume from stock: (144 ng ÷ [concentration]) × 20 µL = X µL
3. Total Syber MM: 5.0 µL × 18 = 90 µL
4. Total primer: 0.5 µL × 18 = 9 µL
5. Total volume needed: 10 µL × 18 = 180 µL
6. ddH₂O needed: 180 - 90 - 9 - X = Y µL
    

Dilution Calculations

Using M₁V₁ = M₂V₂

Standard Dilution

To dilute 245 ng/µL cDNA to 8 ng/µL in 4.5 µL:

  • M₁ = 245 ng/µL
  • V₁ = ?
  • M₂ = 8 ng/µL
  • V₂ = 4.5 µL

V₁ = (M₂ × V₂) ÷ M₁ = (8 × 4.5) ÷ 245 = 0.147 µL

Serial Dilution

For primer efficiency curves:

Step Dilution Final [ng]
1Undiluted8
21:24
31:42
41:81
51:160.5
61:320.25

Quality Control Checkpoints

Pre-Experiment Checklist

  • ✓ All reagents thawed and on ice
  • ✓ Cell confluence checked and documented
  • ✓ Sample volumes verified by direct pipetting
  • ✓ Calculations double-checked
  • ✓ Pipetting error margin included (10-20%)
  • ✓ Negative controls prepared

During Experiment

  • ✓ Record actual volumes used
  • ✓ Note cloudiness/appearance of mixes
  • ✓ Document any deviations from protocol
  • ✓ Label all tubes clearly
  • ✓ Quick spin after mixing

Post-Experiment

  • ✓ Check for evaporation in wells
  • ✓ Seal plates properly
  • ✓ Record thermocycler settings
  • ✓ Document any unexpected observations
  • ✓ Store samples appropriately

Results Summary and Next Steps

ASO Project Status

Completed Milestones

Date Milestone Status
July 14 cDNA Synthesis (ProtoScript® II) Complete
July 16 ASO Plate Setup (5µM final dose) Complete
July 17-18 qPCR Plate Setup Complete
July 21 RNA Extraction Complete
July 22 Nanodrop Analysis Complete
July 29-30 qPCR Execution Needs Repeat

Aptamer Project Status

Completed Milestones

Date Milestone Status
August 7 Cell Treatment & Fixation Complete
August 8 Full Staining Protocol (Day 2) Complete
August 11 Imaging (SY5Y cells) Complete
September 5 Revised Protocol with Controls In Progress

Key Learnings

Technical Insights

ASO Optimization
  • Cloudiness indicates proper complex formation
  • Cell confluence critical (70% optimal)
  • Sample volume verification essential
  • Pipetting error margins prevent failures
Aptamer Optimization
  • Increased aptamer concentration improved binding
  • Triton X in blocking buffer enhanced permeability
  • Control wells essential for validation
  • Overnight incubation at 4°C optimal

Future Directions

Immediate Next Steps

  1. ASO Project:
    • Repeat qPCR with fresh ddH₂O
    • Optimize primer efficiency curves
    • Complete data analysis from successful runs
    • Image transfected cells at 5-day timepoint
  2. Aptamer Project:
    • Complete September 5 protocol
    • Image all experimental conditions
    • Compare aptamer-only vs antibody controls
    • Quantify binding efficiency
  3. Data Analysis:
    • Process qPCR CT values
    • Calculate relative expression levels
    • Statistical analysis of knockdown efficiency
    • Correlate with computational model predictions

Long-term Goals

  • Validate top ASO candidates from computational model
  • Test aptamer binding specificity with multiple controls
  • Optimize dosing for both ASOs and aptamers
  • Combine approaches for synergistic effects
  • Prepare protocols for in vivo validation

Experimental Standards and Documentation

Lab Notebook Best Practices

This notebook follows standard scientific documentation practices to ensure reproducibility and traceability:

Date & Time

All entries include date of experiment with clear timeline of procedures.

Detailed Methods

Complete reagent lists, concentrations, volumes, and incubation times documented.

Observations

Real-time notes on unexpected findings, deviations, and quality assessments.

Safety and Compliance

Important Safety Notes
  • All work with cells performed in biosafety cabinet
  • PFA handled with appropriate PPE (toxic fixative)
  • Arsenic treatments performed by trained personnel
  • Waste disposal followed institutional guidelines
  • All reagents stored at recommended temperatures

Acknowledgments

Special thanks to Rachel for sodium arsenic treatments and all team members who contributed to protocol optimization and troubleshooting throughout this project.